1.Modified classification of anemia by RDW.
Hyeong Ki HWANG ; Myung Soo HYUN ; Bong Sup SHIM
Yeungnam University Journal of Medicine 1993;10(1):58-67
The author obtained index of red cell volume distribution width(RDW) and other red cell indices in 210 patients of various hematoncologic conditions and 200 healthy control group using, an automated blood analyzer, Coulter Counter Model S-plus II. This study performed to classify various etiologic anemia based on the MCV and RDW, to evaluate availability to the differential diagnosis in korean anemic distoders somewhat different from etiologies of anemias in foreginers. In the most of cases, the increase or decrease of MCV were always combined the pararell changes of MCH and MCHC: But the values of MCV and RDW were not correlated in control group and patient group. So the terms of heterogenous of homogenous anemia were meaningful morphologic classification than hypochromic or normochromic anemia. The heterogenous microcytic anemia contained iron deficiency anemia. In heterogenous normocytic anemia, myelophthisic anemia, acute leukemia were contained. In heterogenous macrocytic anemia, megaloblastic anemia, hemolytic anemia were contained. The homogenous microcytic anemia was observed in anemia of chronic disorders. In homogenous normocytic anemia, acute blood loss, chronic leukemia, multiple myeloma were contained. The aplastic anemia was belonged to homogenous macrocytic anemia. The diagnostic significance of RDW in hemoglobinopathies is most importhant. But this study was not contained hemoglobinopathies. Instead RDW was very helpful to differential diagnosis of most common anemias, iron deficiency anemia and anemia due to chronic disorders in Korea.
Anemia*
;
Anemia, Aplastic
;
Anemia, Hemolytic
;
Anemia, Iron-Deficiency
;
Anemia, Macrocytic
;
Anemia, Megaloblastic
;
Anemia, Myelophthisic
;
Cell Size
;
Classification*
;
Diagnosis, Differential
;
Erythrocyte Indices
;
Hemoglobinopathies
;
Humans
;
Korea
;
Leukemia
;
Multiple Myeloma
2.The Effect of Alfacalcidol in the Treatment of Idiopathic Myelofibrosis in Children.
Soon Ki KIM ; Jeong Hee KIM ; Dae Hyun LIM ; Jong Woon CHOI ; Byong Kwan SON ; Hyo Seop AHN
Journal of the Korean Pediatric Society 1994;37(3):339-346
Idiopathic myelofibrosis (IMF), which is characterized by marrow fibrosis, leukoerythroblastic anemia, teardrop poikilocytosis and splenomegaly due to extrumedullary hematopoiesis, has known to have no form of therapy. On the ground of the possibility of reversing collagen deposion in IMF using 1, 25dihydroxycholecalciferol [1, 25(OH)2D3], we report here our observations of 5 patients (M:F=1:4) with IMF before and after treatment with 0.5 microgram/day of alfacalcidol, precursor of 1, 25(OH)2D3. In 3 fo 5 patients the hemoglobin rose and in 4 of 5 the platelet count increased. Follow-up marrow examination revealed that marrow trephine reticulin fibrosis decreased according as the amelioration of clinical and laboratory findings. But these did not persist except one patient in spite of the sustained use of alfacalcidol. Our results suggest that alfacalcidol may have a therapeutic role in some patients with IMF. More extensive studies will be clarify the action of alfacalcidol in IMF.
Anemia, Myelophthisic
;
Bone Marrow
;
Child*
;
Collagen
;
Fibrosis
;
Follow-Up Studies
;
Hematopoiesis
;
Humans
;
Platelet Count
;
Primary Myelofibrosis*
;
Reticulin
;
Splenomegaly